Centers for Disease Control and Prevention Advisory Committee on Immunization Practice Records of the Meeting Held on February 21-22, 2001

By Department of Health and Human Services

Book Id: WPLBN0000002052
Format Type: PDF eBook:
File Size: 0.3 MB
Reproduction Date: 2005

Title:	Centers for Disease Control and Prevention Advisory Committee on Immunization Practice Records of the Meeting Held on February 21-22, 2001
Author:	Department of Health and Human Services
Volume:
Language:	English
Subject:	Health., Medical research, Medical reports
Collections:	Medical Library Collection
Historic Publication Date:
Publisher:	Centers for Disease Control and Prevention


Citation APA MLA Chicago Of Health And Human Services, B. D. (n.d.). Centers for Disease Control and Prevention Advisory Committee on Immunization Practice Records of the Meeting Held on February 21-22, 2001. Retrieved from http://www.gutenberg.cc/

Excerpt
Agenda Item Purpose/Action Presider/Presenter(s) February 21 8: 30 Welcome Dr. J. Modlin (Chair, ACIP) Disclosure by Committee Members Dr. D. Snider (CDC, OD) 9: 00 Influenza vaccine Information Dr. Carolyn Bridges (NCID,DVRD) U.S. influenza surveillance summary Discussion Dr. N. Cox (NCID, DVRD) International update and vaccine selection Decision Dr. K. Fukuda (NCID,DVRD) for 2001-2002 influenza season 2001-2002 Control and Prevention of Influenza Recommendations...

Table of Contents
TABLE OF CONTENTS FEBRUARY 21, 2001 Opening Comments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Financial Disclosure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Workgroup Formation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 AGENDA ITEMS Influenza Vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Changes to the 2001 Recommendations . . . . . . . . . . . . . . . . . . . . . . . . 3 Influenza Vaccine Supply and Delay . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Vaccine Development/Distribution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 CDC Influenza Vaccine Contracting and Program Operations . . . . . . . . 9 Live Attenuated Influenza Vaccine (LAIV) Update . . . . . . . . . . . . . . . . 12 Smallpox Vaccination Recommendations . . . . . . . . . . . . . . . . . . . . . . . 14 Update on Tetanus/Diphtheria Vaccines . . . . . . . . . . . . . . . . . . . . . . . . 17 Update on the Td Shortage/Potential DTaP Shortage . . . . . . . . . . . . . 19 Update on Thimerosal Issues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Polio Outbreak in Hispaniola . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 Dose Reduction of IPV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 OPV Stockpile in the U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 Public comment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 FEBRUARY 22, 2001 Hib Dose Optimization Workgroup Report . . . . . . . . . . . . . . . . . . . . . . 35 Unfinished Business: Draft Language to Address of a DTaP Shortage 37 Updates National Immunization Program (NIP). . . . . . . . . . . . . . . . . . . . . 38 Food and Drug Administration (FDA) . . . . . . . . . . . . . . . . . . . . . 40 National Institutes of Health . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 National Vaccine Injury Compensation Program (NVICP) . . . . . 42 National Vaccine Program Office Update (NVPO) . . . . . . . . . . . 44 National Vaccine Advisory Committee (NVAC) . . . . . . . . . . . . . 45 National Center for Infectious Diseases (NCID) . . . . . . . . . . . . . 46 Changes in the General Recommendations Statement . . . . . . . . . . . . 47 Hepatitis B Vaccine and Multiple Sclerosis . . . . . . . . . . . . . . . . . . . . . . 49 IOM Report of the Immunization Safety Committee . . . . . . . . . . . . . . . 50 Discontinuation of Cholera/Typhoid Fever Vaccines Manufacture . . . . 52 APERT Trial Presentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52 Update on Hepatitis A Vaccine Activities . . . . . . . . . . . . . . . . . . . . . . . 57 Cost Effectiveness of Universal Childhood Hepatitis A Vaccine . . . . . . 60 Staphylococcal Vaccination Phase II Efficacy Trial . . . . . . . . . . . . . . . . 62 Public Comment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66